Skip to content
Orion_products-main-image_2024_1920x1080.png

Our Products

Orion Pharma Ireland supply a wide range of prescription only medications to hospitals and pharmacies across the Republic of Ireland. Patient safety has been a priority for us for more than a hundred years and it continues to be the cornerstone of our daily operations and we play a significant role in ensuring reliable supply of medications – even in the wake of a crisis.

Orion's products are sold in over a hundred countries. Our product portfolio includes proprietary drugs developed by Orion itself, generic drugs, self-care products - such as non-prescription medicines.

Orion Pharma Ireland became operational in 1995 with a portfolio of proprietary and generic medicines for the treatment of respiratory disease, menopause, pain, prostate cancer, Parkinson’s disease and intensive care sedation.

 

For Patients:

We would like to remind you that if you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority (HPRA) website: www.hpra.ie  or email medsafety@hpra.ie  By reporting side affects you can help provide more information on the safety of medicines.

For Healthcare Professionals:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the HPRA website: www.hpra.ie. Adverse events should also be reported to Orion Pharma. If you have any further questions, please contact Orion pharma medical information on +353 1 468 8482 / ie.medicalinformation@orionpharma.com or at our office address.

All the information and personal data you share with us will be protected in line with Orion Pharma policy and the General Data Protection Regulation (GDPR). Product related questions are stored, and part of the information provided by you may be reported to authorities and shared with partner companies because of the requirement to constantly monitor the safety and quality of our products.  All the information supplied by you will be handled confidentially. You have a right of access to the personal data that we hold about you. 

Information on the collection and processing of personal Data can be found at https://www.orion.fi/en/privacy

Information on Orion Pharma’s Patient Safety Statement can be found at https://www.orion.fi/en/patient-safety-policy/  

All Orion Pharma products marketed in Ireland are listed in alphabetical order on the Irish Pharmaceutical Healthcare Association's database of medicines.

Please click on the link “medicines.ie” to access the list. For information on individual products please click on the medicine name.

 

SEPTEMBER 2024/CORP-842c